In T2DM with CKD, semaglutide reduced major kidney disease events at 3 y
- PMID: 39222509
- DOI: 10.7326/ANNALS-24-01579-JC
In T2DM with CKD, semaglutide reduced major kidney disease events at 3 y
Abstract
Perkovic V, Tuttle KR, Rossing P, et al; FLOW Trial Committees and Investigators. Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes. N Engl J Med. 2024;391:109-121. 38785209.
Conflict of interest statement
Comment on
-
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes.N Engl J Med. 2024 Jul 11;391(2):109-121. doi: 10.1056/NEJMoa2403347. Epub 2024 May 24. N Engl J Med. 2024. PMID: 38785209 Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources